Kayne Anderson Rudnick Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86K | Buy |
+5
| New | +$1.86K | ﹤0.01% | 858 |
|
|
2025
Q1 | – | Sell |
-4
| Closed | -$1.08K | – | 966 |
|
|
2024
Q4 | $1.08K | Buy |
+4
| New | +$1.08K | ﹤0.01% | 878 |
|
|
2024
Q2 | – | Sell |
-4
| Closed | -$598 | – | 999 |
|
|
2024
Q1 | $598 | Hold |
4
| – | – | ﹤0.01% | 897 |
|
|
2023
Q4 | $766 | Hold |
4
| – | – | ﹤0.01% | 856 |
|
|
2023
Q3 | $708 | Hold |
4
| – | – | ﹤0.01% | 767 |
|
|
2023
Q2 | $760 | Buy |
+4
| New | +$760 | ﹤0.01% | 771 |
|
|
2022
Q2 | – | Sell |
-9
| Closed | -$1K | – | 603 |
|
|
2022
Q1 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 615 |
|
|
2021
Q1 | – | Sell |
-6
| Closed | -$1K | – | 564 |
|
|
2020
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 566 |
|